| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aneuploidy identification in pre-B acute lymphoblastic leukemia patients at diagnosis by Multiplex Ligation-dependent Probe Amplification (MLPA)
|
Vázquez-Reyes, A.
|
|
2017
|
59 |
C |
p. 117-123
|
artikel
|
| 2 |
A novel spliced variant of the TIN2 shelterin is present in chronic lymphocytic leukemia
|
Ishdorj, Ganchimeg
|
|
2017
|
59 |
C |
p. 66-74
|
artikel
|
| 3 |
Antileukemic activity and cellular effects of the antimalarial agent artesunate in acute myeloid leukemia
|
Kumar, Bijender
|
|
2017
|
59 |
C |
p. 124-135
|
artikel
|
| 4 |
A rare e13a3 (b2a3) BCR-ABL1 fusion transcript with normal karyotype in chronic myeloid leukemia: The challenges in diagnosis and monitoring minimal residual disease (MRD)
|
Duan, M.-H.
|
|
2017
|
59 |
C |
p. 8-11
|
artikel
|
| 5 |
Corrigendum to “KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study” [Leuk. Res. 50 (Nov) (2016) 123–131. PubMed PMID: 27736729]
|
Swords, Ronan T.
|
|
2017
|
59 |
C |
p. 65
|
artikel
|
| 6 |
Development of a harmonized patient-reported outcome questionnaire to assess myelofibrosis symptoms in clinical trials
|
Gwaltney, Chad
|
|
2017
|
59 |
C |
p. 26-31
|
artikel
|
| 7 |
Editorial board and publication information
|
|
|
2017
|
59 |
C |
p. IFC
|
artikel
|
| 8 |
Exome sequencing reveals DNMT3A and ASXL1 variants associate with progression of chronic myeloid leukemia after tyrosine kinase inhibitor therapy
|
Kim, TaeHyung
|
|
2017
|
59 |
C |
p. 142-148
|
artikel
|
| 9 |
Haploidentical allogeneic hematopoietic stem cell transplantation compared to matched unrelated transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
|
Gu, Bin
|
|
2017
|
59 |
C |
p. 41-46
|
artikel
|
| 10 |
Haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia in the imatinib era
|
Chen, Huan
|
|
2017
|
59 |
C |
p. 136-141
|
artikel
|
| 11 |
High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphoma
|
Dlouhy, Ivan
|
|
2017
|
59 |
C |
p. 20-25
|
artikel
|
| 12 |
Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic Trials
|
Strickland, Stephen A
|
|
2017
|
59 |
C |
p. 55-64
|
artikel
|
| 13 |
Living with the burden of relapse in multiple myeloma from the patient and physician perspective
|
Hulin, Cyrille
|
|
2017
|
59 |
C |
p. 75-84
|
artikel
|
| 14 |
Mast cell leukemia (MCL): Clinico-pathologic and molecular features and survival outcome
|
Jain, Preetesh
|
|
2017
|
59 |
C |
p. 105-109
|
artikel
|
| 15 |
MicroRNAs that affect the Fanconi Anemia/BRCA pathway are downregulated in imatinib-resistant chronic myeloid leukemia patients without detectable BCR-ABL kinase domain mutations
|
Yap, E
|
|
2017
|
59 |
C |
p. 32-40
|
artikel
|
| 16 |
Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis
|
Masarova, Lucia
|
|
2017
|
59 |
C |
p. 110-116
|
artikel
|
| 17 |
Preclinical activity of FF-10501-01, a novel inosine-5′-monophosphate dehydrogenase inhibitor, in acute myeloid leukemia
|
Yang, Hui
|
|
2017
|
59 |
C |
p. 85-92
|
artikel
|
| 18 |
Prognostic factors on graft-versus-host disease-free and relapse-free survival after allogeneic hematopoietic stem cell transplantation for adults with acute leukemia
|
Tan, Jie
|
|
2017
|
59 |
C |
p. 1-7
|
artikel
|
| 19 |
Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine – A retrospective single center experience
|
Leisch, M.
|
|
2017
|
59 |
C |
p. 12-19
|
artikel
|
| 20 |
Risk factors and mechanisms contributing to TKI-induced vascular events in patients with CML
|
Valent, Peter
|
|
2017
|
59 |
C |
p. 47-54
|
artikel
|
| 21 |
Sharing post-AML consolidation supportive therapy with local centers reduces patient travel burden without compromising outcomes
|
Hershenfeld, Samantha A.
|
|
2017
|
59 |
C |
p. 93-96
|
artikel
|
| 22 |
Targeting autophagy in multiple myeloma
|
Yun, Zhuang
|
|
2017
|
59 |
C |
p. 97-104
|
artikel
|
Tijdschrift beschrijving